07.01.19
Tarrytown, NY
www.prestigebrands.com
Sales: $240 million
Sales: $240 million (estimated) for personal care products. Corporate sales: $975.8 million.
Key Personnel: Ron Lombardi, chairman, president and chief executive officer; Christine Sacco, chief financial officer; William P’Pool, senior vice president, general counsel and corporate secretary; Timothy J. Connors, executive vice president, sales and marketing; Mary Beth Fritz, senior vice president, quality and regulatory affairs; Chris Heye, senior vice president, Canada, women’s health, and strategic planning; Jeff Zerillo, senior vice president, operations.
Major Products: A range of health and personal care products including oral care, OTC skin care, pain products, digestive aids, women’s and children’s health and more. Oral care brands include DenTek, Efferdent, Effergrip, FreshGuard, GlyOxide, Orabrush and The Doctor’s Night Guard. Skin care and personal care ranges include Compound W, Dermarest, Nix Americane, Boil Ease, Ting and Wartner, Boudreaux’s Butt Paste.
.
New Products: Boudreaux’s Butt Paste with Natural Aloe, DenTek Comfort Picks Wallet Card, Nix Ultra Lice Removal Kit, Summer’s Eve Simply Coconut Water Wash cleanser.
Comments: Just about one year ago, Prestige sold its dwindling household cleaning business for $69 million in cash; the sector had contributed $80.6 million or 8% of total company sales in fiscal 2018. The unit included well-known home care brands such as Comet, Spic and Span and Chore Boy, but had been on a downward trajectory for years. KIK was the buyer.
The sale paved the way for Prestige to create a new company name that is more reflective of its core consumer healthcare focus: Prestige Consumer Healthcare, Inc. The company continues to trade under the symbol PBH.
Companywide revenues for fiscal 2019 fell 6.3% to $975.8 million. Positive consumption levels across core brands were offset by the divestiture of the household cleaning segment, according to the company. Revenues for the North American OTC Healthcare segment decreased 0.7% while the International OTC Healthcare segment saw revenues rise 2.0%. Organic revenue for the year increased 0.1%.
Prestige relies on contract manufacturers to produce a large portion of its products. As of March 31, 2019, the company had relationships with 113 third party manufacturers. Of those, it had long-term contracts with 33 that produced items that accounted for approximately 65.6% of gross sales for 2019, compared to 46 manufacturers with long-term contracts that accounted for approximately 73.6% of gross sales in 2018.
www.prestigebrands.com
Sales: $240 million
Sales: $240 million (estimated) for personal care products. Corporate sales: $975.8 million.
Key Personnel: Ron Lombardi, chairman, president and chief executive officer; Christine Sacco, chief financial officer; William P’Pool, senior vice president, general counsel and corporate secretary; Timothy J. Connors, executive vice president, sales and marketing; Mary Beth Fritz, senior vice president, quality and regulatory affairs; Chris Heye, senior vice president, Canada, women’s health, and strategic planning; Jeff Zerillo, senior vice president, operations.
Major Products: A range of health and personal care products including oral care, OTC skin care, pain products, digestive aids, women’s and children’s health and more. Oral care brands include DenTek, Efferdent, Effergrip, FreshGuard, GlyOxide, Orabrush and The Doctor’s Night Guard. Skin care and personal care ranges include Compound W, Dermarest, Nix Americane, Boil Ease, Ting and Wartner, Boudreaux’s Butt Paste.
.
New Products: Boudreaux’s Butt Paste with Natural Aloe, DenTek Comfort Picks Wallet Card, Nix Ultra Lice Removal Kit, Summer’s Eve Simply Coconut Water Wash cleanser.
Comments: Just about one year ago, Prestige sold its dwindling household cleaning business for $69 million in cash; the sector had contributed $80.6 million or 8% of total company sales in fiscal 2018. The unit included well-known home care brands such as Comet, Spic and Span and Chore Boy, but had been on a downward trajectory for years. KIK was the buyer.
The sale paved the way for Prestige to create a new company name that is more reflective of its core consumer healthcare focus: Prestige Consumer Healthcare, Inc. The company continues to trade under the symbol PBH.
Companywide revenues for fiscal 2019 fell 6.3% to $975.8 million. Positive consumption levels across core brands were offset by the divestiture of the household cleaning segment, according to the company. Revenues for the North American OTC Healthcare segment decreased 0.7% while the International OTC Healthcare segment saw revenues rise 2.0%. Organic revenue for the year increased 0.1%.
Prestige relies on contract manufacturers to produce a large portion of its products. As of March 31, 2019, the company had relationships with 113 third party manufacturers. Of those, it had long-term contracts with 33 that produced items that accounted for approximately 65.6% of gross sales for 2019, compared to 46 manufacturers with long-term contracts that accounted for approximately 73.6% of gross sales in 2018.
